Literature DB >> 9755737

Relapse of depression in primary care. Rate and clinical predictors.

E H Lin1, W J Katon, M VonKorff, J E Russo, G E Simon, T M Bush, C M Rutter, E A Walker, E Ludman.   

Abstract

OBJECTIVE: To determine the clinical predictors and rate of relapse for major depression in primary care.
DESIGN: A cohort study of subjects in 2 randomized trials of depressed patients diagnosed and prescribed antidepressant medicine by primary care physicians. Baseline, 7-month, and 19-month assessments were conducted.
SETTING: A large primary care clinic of a staff-model health maintenance organization. PATIENTS: Two hundred fifty-one primary care patients who did not satisfy Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) criteria for major depression at 7 months. MAIN OUTCOME MEASURES: Relapse was defined as (1) satisfying DSM-III-R criteria for major depression at 19 months, or (2) reporting an interval episode of 2 weeks or more of depressed mood and symptoms between 7 and 19 months. Predictors examined included demographic characteristics, medical comorbidity, disability, and psychological symptoms. Depressive symptoms were measured by Inventory of Depressive Symptoms and Hopkins Symptoms Checklist.
RESULTS: Of the patients, 37.1% reported relapse of depression in the 12-month relapse-risk period. The 2 major risk factors associated with relapse were (1) persistence of subthreshold depressive symptoms 7 months after the initiation of antidepressant therapy (odds ratio, 3.3; 95% confidence interval, 2.74-3.93) and (2) history of 2 or more episodes of major depression, or chronic mood symptoms for 2 years (odds ratio, 2.1; 95% confidence interval, 1.41-2.76). Patients with both risk factors were approximately 3 times more likely to relapse than patients with neither.
CONCLUSIONS: The relapse rate among primary care patients treated for depression approached that of specialty samples, with more than one third reporting relapse in 1 year. Clinical characteristics can help target high-risk patients for relapse prevention efforts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755737     DOI: 10.1001/archfami.7.5.443

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  41 in total

1.  Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studies.

Authors:  Bruno R Barros; Alexander Schacht; Michael Happich; Foula Televantou; Lovisa Berggren; Daniel J Walker; Hector J Dueñas
Journal:  Prim Care Companion CNS Disord       Date:  2014-10-02

2.  Racial/ethnic differences in the association between obesity and major depressive disorder: findings from the Comprehensive Psychiatric Epidemiology Surveys.

Authors:  Amelia R Gavin; Tessa Rue; David Takeuchi
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

3.  Costs and benefits of direct-to-consumer advertising: the case of depression.

Authors:  Adam E Block
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Counseling via analogy: improving patient adherence in major depressive disorder.

Authors:  Boadie W Dunlop; Anne L Dunlop
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

5.  Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?

Authors:  Daniel J Taylor; Heather M Walters; Jeffrey R Vittengl; Steven Krebaum; Robin B Jarrett
Journal:  J Affect Disord       Date:  2009-09-05       Impact factor: 4.839

6.  Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

Authors:  J E J Buckman; A Underwood; K Clarke; R Saunders; S D Hollon; P Fearon; S Pilling
Journal:  Clin Psychol Rev       Date:  2018-07-29

Review 7.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 8.  Pharmacotherapy to sustain the fully remitted state.

Authors:  Sidney Kennedy; Roger McIntyre; Angelo Fallu; Raymond Lam
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

Review 9.  Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.

Authors:  Giovanni A Fava; Chiara Ruini; Nicoletta Sonino
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care.

Authors:  Luis Agüera; Inmaculada Failde; Jorge A Cervilla; Paula Díaz-Fernández; Juan Antonio Mico
Journal:  BMC Fam Pract       Date:  2010-03-03       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.